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The type I interferons (IFNs) are potent mediators of antiviral immunity, and many viruses have developed
means to block their expression or their effects. Semliki Forest virus (SFV) infection induces rapid and
profound silencing of host cell gene expression, a process believed to be important for the inhibition of the IFN
response. In SFV-infected cells, a large proportion of the nonstructural protein nsp2 is found in the nucleus,
but a role for this localization has not been described. In this work we demonstrate that a viral mutant,
SFV4-RDR, in which the nuclear localization sequence of nsp2 has been rendered inactive, induces a signif-
icantly more robust IFN response in infected cells. This mutant virus replicates at a rate similar to that of the
parental SFV4 strain and also shuts off host cell gene expression to similar levels, indicating that the general
cellular shutoff is not responsible for the inhibition of IFN expression. Further, the rate of virus-induced
nuclear translocation of early IFN transcription factors was not found to differ between the wild-type and
mutant viruses, indicating that the effect of nsp2 is at a later stage. These results provide novel information
about the mode of action of this viral IFN antagonist.
Type I interferons (type I IFNs) are central players in initi-
ation of innate immune defenses to virus infections. By up-
regulating many antiviral genes, their actions establish an an-
tiviral state. Induction of type I IFN in most cell types is
triggered by recognition of viral replication intermediates, such
as double-stranded RNA in the cytoplasm. Detection of dou-
ble-stranded RNA is mediated by retinoic acid-inducible gene
I and melanoma differentiation-associated factor 5 (21, 22, 42),
which activate latent type I IFN transcription factors, namely
IFN regulatory factor 3 (IRF-3), nuclear factor kappa B (NF-
B), and activating protein 1. IRF-3 is activated by phos-
phorylation and dimerization, while NF-B is activated by
degradation of its inhibitory protein, IB. The activated tran-
scription factors relocate to the nucleus, where they promote
the transcription of genes for early type I IFNs, beta interferon
(IFN-), and alpha 4 interferon (IFN-4). Expression and
secretion of these early type I IFNs lead to autocrine and
paracrine stimulation of the cell surface alpha/beta interferon
(IFN-/) receptor (IFNAR1), resulting in expression of the
late type I IFN subsets. Many genes are upregulated upon type
I IFN stimulation, and together these constitute activities
which block the spread of many diverse virus infections. The
coevolution of viruses with their hosts has ensured that many
viral strategies exist for antagonizing the activation of these
transcription factors to promote viral replication and spread
(18). IRF-3 activity is targeted by many viruses, including hep-
atitis C virus and rotavirus, in order to suppress the expression
of type I IFN. Similarly, several viral NF-B antagonists are
known. Most, including for example vaccinia virus K1L, hep-
atitis C virus Core, and HIV Vpu, inhibit degradation of IB,
maintaining NF-B in its inactive cytoplasmic form. Another
viral antagonist of this pathway, the A238L protein of African
swine fever virus, inhibits NF-B activity at a later stage (38);
the A238L protein is an IB homologue and associates with
cytoplasmic p65 after proteasome-mediated degradation of en-
dogenous IB. In another strategy, the 3C protease of polio-
virus cleaves and inactivates NF-B (31).
Semliki Forest virus (SFV) is an RNA virus of the alphavirus
genus of the Togaviridae family. The virus particles are envel-
oped and contain a single-stranded positive-sense 42S RNA
genome. The 5 two-thirds area of the genome codes for the
viral nonstructural proteins 1 to 4 (nsp1 to -4), which are
translated directly from this genomic RNA. The structural
proteins are encoded within the 3 one-third of the genome
and are translated from a subgenomic 26S mRNA. The non-
structural proteins together with cellular proteins form the
viral replicase complex, which catalyzes the production of new
viral 42S and 26S RNAs via a negative-strand intermediate.
Infection of cells in culture or in vivo with SFV results in the
induction of type I IFNs; indeed, many studies have used SFV
as a positive control for the induction of IFN.
A major event in the infection of cells with SFV and related
viruses is the profound inhibition of cellular transcription and
translation, which favors the production of viral RNA and
proteins. Very soon after infection, the profile of total cellular
macromolecular synthesis changes from cellular RNAs and
proteins to predominantly viral gene products. Various mech-
anisms have been proposed for this (12, 17, 27, 30, 37, 41), but
the exact series of events remains obscure. The virus benefits
from this shutoff of host molecular synthesis as it frees com-
* Corresponding author. Mailing address: Department of Microbi-
ology, Tumor and Cell Biology, Karolinska Institutet, Box 280, S-171
77 Stockholm, Sweden. Phone: 46-8-52487218. Fax: 46-8-337412.
E-mail: gerald.mcinerney@ki.se.
† L.B. and P.D. contributed equally to this work.
 Published ahead of print on 6 June 2007.
8677
ponents of the cellular gene expression apparatus for the pro-
duction of virus products. It has been proposed that the shutoff
also benefits the virus by reducing the capacity of the infected
cell to signal, via type I IFNs and other cytokines, to surround-
ing cells, thus expediting virus propagation (13, 16).
Each of the nsp’s has discrete activities within the infected
cell. nsp1 is involved in modification of intracellular mem-
branes. nsp3 has an important but yet-undefined function. nsp4
is the RNA-dependent RNA polymerase. nsp2, the most well
studied of the SFV nsp’s, is a papain-like protease responsible
for processing the viral nonstructural polypeptide to release
each nsp in a temporally regulated manner (40). It also has
NTPase, RNA helicase, and RNA triphosphatase activities
(15, 33, 34). In infected cells, a large proportion of nsp2 is
found in association with the nuclear matrix, although its func-
tion there is unknown (32). The nuclear localization sequence
of nsp2 consist of a core nonapeptide (A645LPRRRVTWN)
(35); however, in fusion constructs, a larger fragment is re-
quired to direct nuclear translocation of -galactosidase (35).
Mutation of the second R residue of the nsp2 nuclear local-
ization sequence to D results in a virus termed SFV4-RDR, in
which nsp2 does not translocate to the nucleus (35). Apart
from a short lag period, SFV4-RDR has replication kinetics
similar to that of parental SFV4 in BHK cells (33). The short
lag phase is most likely due to a slower processing of the nsp12
precursor. Although cellular DNA synthesis is not inhibited by
SFV4-RDR as much as by SFV4 infection, levels of cellular
transcription and translation inhibition are similar (33). De-
spite the similarities in tissue culture, SFV4 is neurovirulent in
BALB/c mice, whereas SFV4-RDR is not (33). SFV4-RDR
infection results in only limited focal central nervous system
infection and limited cell damage (10). However, in IFNAR1-
defective mice, which have no functional type I IFN system,
SFV4-RDR and SFV4 are equally virulent, indicating that the
differences observed relate to interaction of these viruses with
the type I IFN system (10).
In the present work, we have analyzed the role of type I IFN
in the control of SFV4-RDR virus replication. Using primary
mouse embryo fibroblast (MEF) cells competent for produc-
tion of and reaction to type I IFNs, we show that despite
efficient inhibition of cellular transcription and translation,
SFV4-RDR infection induces significantly more type I IFN
than does SFV4 infection. Our results therefore indicate that
nuclear localization of nsp2 or a function within the region of
nsp2 containing the nuclear localization signal normally sup-
presses type I IFN production in SFV-infected cells.
MATERIALS AND METHODS
Cells and viruses. BHK-21 cells (ATCC) were cultured in Glasgow minimal
essential medium supplemented with 5% fetal calf serum (FCS) (Sigma), 20 mM
HEPES, 10% tryptose phosphate broth, 2 mM L-glutamine, and penicillin-strep-
tomycin (Invitrogen). Wild-type (wt) B6, wt sv129, and IFNAR/ sv129 MEFs
(obtained from 12- to 13-day-old fetuses) and L929 cells were cultured in Dul-
becco’s modified Eagle’s medium (Sigma) supplemented with 10% FCS, 4 mM
L-glutamine, and penicillin-streptomycin. wt SFV4 and SFV4-RDR were both
derived from the SFV4 infectious clone (pSP6-SFV4) as described previously
(25). Virus titration was performed by quantification of plaque numbers on wt
MEF cells. SFV4 stocks were used for infection as follows: cell monolayers were
washed with phosphate-buffered saline (PBS), and virus was added in 300 l
minimal essential medium (Invitrogen) supplemented with 0.2% bovine serum
albumin, 2 mM L-glutamine, and 20 mM HEPES with periodic shaking for 1 h at
37°C. Virus solutions were then removed and cells washed with PBS before
addition of prewarmed complete medium.
RNA extraction and quantitative PCR. At various times postinfection, cells
incubated with virus were trypsinized, removed from the flask, and pelleted by
gentle centrifugation. Cell pellets were immediately snap-frozen on dry ice
and stored at 70°C. RNA was extracted from 40 mg of cell pellet using the
QIAGEN RNeasy Mini kit following the manufacturer’s protocol. RNA quality
and quantity were assessed on an Agilent bioanalyzer (Agilent technologies)
using the RNA 6000 Nano assay. High-quality RNA samples were reverse tran-
scribed as described previously (28). To minimize variability, samples to be
directly compared were reverse transcribed at the same time using the same
master mix (all reagents were from Invitrogen). Standards and test samples were
always assayed in triplicate. Briefly, in a total volume of 20 l (made up in
RNase-free water), reaction mixes contained the following: 50 pM of each
primer, 40 mM deoxynucleoside triphosphates, 25 mM MgCl2, 1:20,000 SYBR
Green (Biogene Ltd.), 5 U Fast Start Taq (Roche Applied Science), and 2 l
cDNA. Tubes were heated to 94°C for 5 min, and the PCR was then cycled
through 94°C for 20 s, 62°C for 20 s, and 72°C for 20 s for 40 cycles on a
RotorGene 3000 instrument (Corbett Research). Cell culture-derived samples
were normalized to total RNA determined on an Agilent bioanalyzer. Sequences
of the primers used in the assay were as follows: SFV4, 5-CGCATCACCTTC
TTTTGTG-3 and 5-CCAGACCACCCGAGATTTT-3; IFN-, 5-CACAGC
CCTCTCCATCAACT-3 and 5-GCATCTTCTCCGTCATCTCC-3; -actin,
5-CGTTGACATCCGTAAAGACC-3 and 5-CTGGAAGGTGGACAGTGA
G-3; glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 5-AACTCCCACTC
TTCCACCTT-3 and 5-GCCCCTCCTGTTATTATGG-3.
Type I IFN bioassay. A bioassay was employed to determine the total amount
of active IFN-/ (20). Briefly, flat-bottomed 96-well plates were seeded with
1.5  104 L929 cells/well. The following day, twofold serially diluted samples or
an IFN-/ standard (Gu02-901-511; National Institute for Allergy and Infec-
tious Diseases) was added to the cells. After overnight incubation, the cells were
infected with SFV4 (350 IU/well). Mitochondrial dehydrogenase activity was
assayed 2 days after infection using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tet-
razolium bromide according to the instructions of Sigma kit CGD-1. The 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide was dissolved in OPTI
MEM reduced-serum medium lacking phenol red (Invitrogen) supplemented
with 2% FCS, 2 mM L-glutamine, and penicillin-streptomycin. The absorbance
was read at 570 nm and normalized against the absorbance at 630 nm in a
microplate reader (Elx 800 UV; BIO-TEK Instruments, Winooski, Vermont).
The data were converted to international units using murine IFN-/ as a
standard (National Institute for Allergy and Infectious Diseases, NIH) in all
assays. Samples were considered below the level of detection if the signal did not
reach three-quarters of the plateau level of the standard. All samples analyzed in
the bioassay were UV inactivated to abolish any residual infectivity of the viral
particles used for stimulation. Levels of tumor necrosis factor alpha (TNF-)
were quantified by enzyme-linked immunosorbent assay (ELISA) (R&D Sys-
tems) according to the manufacturer’s instructions.
Western blotting. For analysis of protein by Western immunoblotting, cells
were lysed on ice in lysis buffer (1% NP-40, 50 mM Tris-HCl [pH 7.6], 150 mM
NaCl, 2 mM EDTA) and clarified by centrifugation at 6,000  g for 5 min in a
microcentrifuge at 4°C. The protein concentration was determined with the
Bio-Rad DC protein assay, and equal amounts were separated by 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to
Hybond-P membranes (Amersham), and blotted with rabbit polyclonal antibod-
ies specific for either phospho-eIF2 (phosphorylated on serine 51; Biosource)
or total eIF2 (Santa Cruz). The secondary antibody was horseradish peroxi-
dase-conjugated goat antirabbit serum (BD Biosciences). Chemiluminescence
was detected using ECL reagents (Amersham). Membranes were stripped by
washing in 100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl (pH
6.7) for 45 min at 50°C, washed, blocked, and probed again as described above.
Protein expression assays. For metabolic labeling of virus-infected cultures,
cells were incubated first in methionine-free minimum essential medium supple-
mented with 2 mM L-glutamine and 20 mM HEPES (starvation medium) for 20
min. Newly produced proteins were then labeled by incubation in starvation
medium supplemented with 50 Ci/ml [35S]methionine (Amersham) for 10 min
(Pulse medium). Cells were then washed in cold PBS, lysed on ice in lysis buffer,
and clarified by centrifugation at 6,000  g for 5 min in a microcentrifuge at 4°C.
The protein concentration was determined using the Bio-Rad DC protein assay,
and equal quantities were then analyzed on 10% SDS-PAGE gels, which were
subsequently dried and subjected to autoradiography. Densitometry analysis was
performed using Bio-Rad Quantity One software.
RNA quantitation by [14C]uridine labeling. Equal numbers of MEF cells were
infected as described above with SFV4 or SFV4-RDR. For labeling, the medium
8678 BREAKWELL ET AL. J. VIROL.
was removed and replaced with complete medium containing 1 Ci/ml [14C]uri-
dine (Amersham). After the labeling period, total cell RNA was isolated using
the GenElute kit (Sigma) according to the manufacturer’s instructions and quan-
tified by spectrophotometry. Equal quantities of each sample were analyzed by
formaldehyde agarose gel electrophoresis. The gel was then soaked for 30 min in
1 M salicylic acid (Sigma), dried, and exposed to X-ray film (Fujifilm). Densi-
tometry analysis was performed using Bio-Rad Quantity One software.
Immunofluorescence. Antibodies used included murine anti-SFV4 E2, murine
anti-SFV4 replicase, goat anti-IRF-3 (Santa Cruz), and goat anti-NF-B p65
(Santa Cruz). Secondary antibodies were Cy3-conjugated donkey antigoat sera
and Cy2-conjugated donkey antimouse serum (both ML grade from Jackson
Immunoresearch). Immunofluorescence was performed as previously described
(27). Briefly, cells grown on coverslips were fixed by incubation in 4% paraform-
aldehyde (in PBS) for 8 to 10 min at room temperature, followed by incubation
in methanol for 8 to 10 min at 20°C. The coverslips were blocked, and primary
antibodies were diluted in blocking buffer and incubated with the cells for 1 to
3 h. Secondary antibodies were diluted in blocking buffer containing 0.5 g/ml
Hoechst 33258 (Molecular Probes) for identification of cell nuclei. Washed
coverslips were then mounted in vinol mounting medium, and images were
captured using a Leitz DM RB fluorescence microscope.
RESULTS
SFV4-RDR is attenuated for growth in type I IFN-competent
cells. Previous experiments comparing SFV4 and SFV4-RDR
showed that the replication kinetics of these two viruses in
BHK cells were similar (33). These experiments, performed at
a high multiplicity of infection (MOI), indicate that the nuclear
localization signal of nsp2 is not important for virus growth, at
least in BHK cells. To compare the abilities of these two
viruses to spread in cells with or without an intact IFN system,
BHK cells and MEFs from IFN-competent B6 mice were in-
fected with SFV4 and SFV4-RDR at a low MOI (0.05), and the
amount of infectious virus released into the media was quan-
tified by plaque assay (Fig. 1A). Upon low-MOI infection of
type I IFN-incompetent BHK cells, SFV4 and SFV4-RDR
replicated with similar kinetics. Both infections produced high
titers by 12 h and led to the death of all cells in the cultures by
24 h. This is consistent with results in the previous study (33)
and shows that the mutant virus had no significant defect in any
step of the viral life cycle in BHK cells. However, when similar
low-MOI infections were performed with type I IFN-compe-
tent B6 MEFs, relative to those of SFV4, SFV4-RDR titers
were reduced. Again, by 12 h, both viruses had grown to high
titers. However, the titer of SFV4 continued to rise until 24 h,
whereas the titer of SFV4-RDR did not, and while all cells
were killed by the SFV4 infection, the SFV4-RDR infection
did not result in complete death of the culture; a significant
fraction of the cells survived. In repeat experiments, these
findings were highly reproducible and indicate that the SFV4-
RDR virus is defective in its ability to spread in a culture of
type I IFN-competent cells.
To confirm that this was not a phenomenon related to other
properties of these two cell types, the studies were repeated
with a second set of interferon-competent and -incompetent
cells, MEFs derived from sv129 wt or sv129-IFNAR1/ mice.
The results are presented in Fig. 1B. Again, in cells lacking a
type I IFN signaling system (the IFNAR1/ cells), the growth
curves of SFV4 and SFV4-RDR were very similar, while in
cells with an intact IFN system, SFV4-RDR replicated less
efficiently than SFV4. In repeat experiments, the final titer of
SFV4-RDR was consistently 	3.5-fold lower than that of
SFV4. As with wt B6 MEFs, many of the SFV4-RDR-infected
wt sv129 MEFs survived, whereas none of the IFNAR1/
cells infected by either virus were viable after 48 h. These
experiments show that although SFV4-RDR replicates well in
IFN-incompetent cells, it is clearly attenuated in wt MEFs
(both B6 and sv129), which are competent for production of
and responses to type I IFNs.
To further investigate this phenomenon, we examined the
viral plaque sizes of SFV4 and SFV4-RDR grown on all
four cell types. The results clearly show that on BHK and
IFNAR/ cell monolayers, the plaque sizes of the two viruses
FIG. 1. (A) BHK (left panel) or wt B6 MEF (right panel) cells were
infected with SFV4 or SFV4-RDR at a MOI of 0.05, samples were
taken at the indicated time points, and infectious virus was quantified
by plaque assay on BHK cells. Data points are averages for three
experiments. (B) sv129 IFNAR1/ (left panel) or wt sv129 (right
panel) MEFs were infected with SFV4 or SFV4-RDR at a MOI of
0.05, samples were taken at the indicated time points, and infectious
virus was quantified by plaque assay on BHK cells. Data points are
averages for two experiments. (C) Comparison of viral plaque sizes of
SFV4 and SFV4-RDR on BHK cells, wt B6 MEFs, sv129 IFNAR1/
MEFS, and wt sv129 MEFs.
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were identical, whereas on both strains of wt MEFs, the SFV4-
RDR plaques were smaller than the SFV4 plaques (Fig. 1C).
In particular, relative to SFV4, SFV4-RDR gave rise to very
small plaques on wt B6 MEFs, indicating that this mutant virus
is severely defective in its ability to spread in these type I
IFN-competent MEFs. The mutant also grew less well than
SFV4 on the sv129 MEFs. Relative to SFV4, SFV-RDR ex-
hibited a reduced-plaque-size phenotype only in wt MEFs of
either background (the small plaques shown on the IFNAR/
MEFs are due to earlier fixing of cells because of crowding on
the plates). Taken together with the in vivo data on these
viruses in IFNAR/ mice (10), these results demonstrate that
relative to SFV4, growth of SFV4-RDR is suppressed by the
action of type I IFN. This could result from differences in IFN
induction by these two viruses or from differences in the sus-
ceptibility of the two viruses to IFN-mediated antiviral activi-
ties.
Infection of MEFs with SFV4-RDR leads to significantly
higher levels of type I IFN. The levels of type I IFN induced in
MEFs infected with SFV4 and SFV4-RDR were determined
using two different assays. First, we measured the amount of
IFN- mRNA in infected cells. At 12 h postinfection (hpi),
total cellular RNA was extracted from triplicate cultures of
sv129 MEFs infected at MOI 50 with SFV4 or SFV4-RDR.
With both viruses, this MOI was observed by immunostaining
to result in infection of 	98% of cells in the culture (data not
shown). Levels of IFN- mRNA transcripts were measured by
quantitative reverse transcriptase PCR (QPCR). Approxi-
mately seven times more IFN- mRNA was produced by
SFV4-RDR-infected cells than by SFV4-infected cells (Fig.
2A). In a second approach, we quantified the levels of func-
tional IFN activity produced by infected cells. Sv129 MEFs
were infected with SFV4 or SFV4-RDR at a MOI of 50.
Supernatants were sampled at 24 hpi, and type I IFN levels
were quantified using a bioassay (20). The results are shown in
Fig. 2B. SFV4-RDR-infected MEFs produced significantly
more functional type I IFN than SFV4-infected cells. Super-
natants were also analyzed by ELISA for levels of the proin-
flammatory cytokine TNF-. Levels were dramatically higher
with SFV4-RDR than with SFV4 (Fig. 2C), indicating that this
effect was not specific to type I IFNs but was also observed for
other virus-induced cytokines. All of the experiments pre-
sented in Fig. 2 were repeated in murine L929 cells, with
similar or even greater differences between the two viruses
(data not shown).
SFV4-RDR induces inhibition of host RNA production as
efficiently as SFV4. The levels of type I IFN produced during
SFV4-RDR infection were much higher than those produced
by SFV4 infection. A similar observation has been made with
nsp2 mutants of the related Sindbis virus (SIN), and here it was
proposed that the increased IFN resulted from an incomplete
inhibition of cellular gene expression; wt SIN completely sup-
presses host cell gene expression, whereas nsp2 mutants do not
(13, 14, 16). To determine whether there were differences in
the shutoff of host cell gene transcription in SFV4- and SFV4-
RDR-infected cells, total cellular RNA was purified from
SFV4-, SFV4-RDR-, or mock-infected MEFs at 12 hpi, and as
representative markers of cellular transcripts, levels of -actin
and GAPDH mRNA were determined by QPCR (Fig. 3A).
Relative to those in the mock-infected control cultures, levels
of these cellular mRNAs were equally reduced in the two virus
infections.
Levels of newly produced RNA in the early stages of virus
infection were also investigated by metabolic labeling. B6
MEFs were infected at a MOI of 50 with SFV4 or SFV4-RDR
or mock infected and labeled for 2-h periods with [14C]uridine.
Total RNA was extracted and analyzed by agarose gel electro-
phoresis. Three labeling periods were used, 1 to 3 hpi, 3 to 5
hpi, and 5 to 7 hpi (Fig. 3B). Several major RNA species were
present in the mock-infected cells; these represent the rRNAs
and their precursors. In cells infected with SFV4 or SFV4-
RDR, even at the earliest 1- to 3-hpi labeling time period, the
major RNA species were the viral genomic 42S RNA and the
subgenomic 26S mRNA, with few rRNAs. This experiment
also demonstrates that the RNA replication kinetics of SFV4
and SFV4-RDR were indistinguishable. In order to quantify
the transcriptional shutoff caused by these two viral infections,
densitometry analysis was performed on two prominent bands,
corresponding to cellular RNAs. Figure 3C shows that while
these two cellular RNAs differ in the extent to which each is
shut off, in neither case is there a difference between cells
infected with SFV4 or SFV4-RDR. It is evident that some
variation of the extent of shutoff exists between individual
experiments, but in each case the values for the two viruses
were very similar. These data indicate that a profound inhibi-
tion of cellular RNA production occurs rapidly in both SFV4-
and SFV4-RDR-infected cells and that this is not different
between these two viruses.
SFV4-RDR induces inhibition of host protein production as
efficiently as SFV4. We also investigated virus-induced inhibi-
tion of cellular translation in SFV4- and SFV4-RDR-infected
cells. Replicate cultures of B6 MEFs were infected at a MOI of
10, and at various times postinfection, cultures were metabol-
ically pulse-labeled with [35S]methionine. Analysis of cell ly-
sates by SDS-PAGE demonstrated that the protein production
profile of SFV4- and SFV4-RDR-infected MEFs changed
from cellular to predominantly viral at similar times (Fig. 4A).
FIG. 2. (A) Total cellular RNA was taken at 12 hpi from MEFs
infected with SFV4 or SFV4-RDR and analyzed by QPCR for IFN-
mRNA levels. Bars represent the mean of triplicate measurements
from a representative experiment, error bars are standard deviations,
and the asterisk indicates a P value of 
0.05 (Student’s t test). (B) Su-
pernatants from SFV4- or SFV4-RDR-infected MEFs were taken at
24 hpi and analyzed by bioassay for levels of functional IFN. Bars
represent the mean of triplicate measurements from a representative
experiment, error bars are standard deviations, and the asterisk indi-
cates a P value of 
0.05 (Student’s t test). (C) Supernatants from
infected MEFs were taken at 24 hpi and analyzed by ELISA for levels
of TNF-. Bars represent the mean of triplicate measurements from
one representative experiment of three.
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Between 2 and 3 hpi, cellular protein synthesis declined sharply
to negligible levels. From 3 hpi onwards, protein synthesis was
mainly devoted to virus structural proteins. In the experiment
shown and in some but not all repeat experiments, viral protein
synthesis in the SFV-RDR-infected cells appeared to begin at
a low level at the 2.5-hpi time point. The cause of this is
unknown, although our analysis of viral RNA production (Fig.
3) suggested that it is likely not due to increased 26S mRNA
production at these times. In any event, it does not appear to
alter the kinetics of shutoff of host protein synthesis. When
densitometric analysis was carried out on the intensity of the
bands corresponding to the cellular protein actin (Fig. 4B), it
was found to be reduced at similar rates in cells infected with
either virus. As with the quantification analysis of transcription
shutoff, there was variation between each experiment, but the
means and the standard deviations for each virus were almost
identical at each time point. Thus, these data show that both
viruses induced shutoff of host cell translation to similar ex-
tents and with similar kinetics. In a separate approach to study-
ing translation, we analyzed the extent of phosphorylation of
the  subunit of the translation initiation factor eIF2. Lysates
from cells infected with SFV4 or SFV4-RDR were prepared
after 5 h of infection and analyzed by immunoblotting for the
phosphorylated and nonphosphorylated forms of this protein.
A representative experiment shown in Fig. 4C shows that the
levels of phosphorylation did not differ between SFV4- and
SFV4-RDR-infected cells. Taken together, the results in Fig. 3
and 4 show that the SFV4-RDR virus does not have a defect in
its ability to interfere with the gene expression apparatus in
infected cells. Thus, the higher levels of antiviral and proin-
flammatory cytokines measured during SFV4-RDR infection
cannot be attributed to a reduced global suppression of host
cell transcription or translation by this virus.
SFV4-RDR does not block the nuclear entry of type I IFN
transcription factors. As discussed above, many viruses have
the ability to specifically block the type I IFN system. One
strategy is to block nuclear translocation of IFN-inducing tran-
scription factors (18). To investigate whether nuclear translo-
cation of IRF-3 or NF-B was suppressed in SFV4- or SFV4-
RDR infected cells, MEFs were infected at both low and high
MOI and fixed at various times after infection, and the loca-
tions of these two transcription factors were investigated by
immunofluorescence. Infected cultures were stained using an-
tibody for either IRF-3 or NF-B and, in order to visualize
virus-infected cells, a monoclonal antibody to the SFV E2
spike protein or to the SFV replicase complex. At 5 hpi in the
low-MOI-infected cells, complete translocation of both tran-
scription factors was seen in every cell which expressed the E2
spike protein in cultures infected with either virus (Fig. 5A).
Analysis at earlier times was made difficult by low viral protein
expression and by the asynchronicity of low-MOI infections in
MEFs. However, it could be seen that the numbers of cells
exhibiting nuclear localization of either transcription factor did
not differ between the two viruses at any time during infection
(data not shown). In order to ensure complete and synchro-
nous infection, this analysis was also performed at a high MOI.
At 3 hpi in cells infected at a high MOI with either virus, all
cells were positive for the SFV replicase and had exhibited
nuclear translocation of both IRF-3 and NF-B (Fig. 5B).
These early components of the type I IFN induction pathway
FIG. 3. (A) Total cellular RNA was taken at 12 hpi from mock-
infected MEFs (black bars) or MEFs infected with SFV4 (gray bars) or
SFV4-RDR (white bars) and analyzed by QPCR for -actin (left
panel) and GAPDH (right panel) mRNA levels. Each bar represents
the mean of triplicate measurements from a representative experi-
ment, and error bars are standard deviations. (B) Total cellular and
viral RNA synthesis was visualized by [14C]uridine labeling between 1
and 3 hpi (lanes 1 to 3), 3 and 5 hpi (lanes 4 to 6), or 5 and 7 hpi (lanes
7 to 9) in wt B6 MEFs mock infected (lanes 1, 4, and 7), infected at an
MOI of 50 with SFV4 (lanes 2, 5, and 8), or infected at a MOI of 50
with SFV4-RDR (lanes 3, 6, and 9). Positions of the viral genomic 42S
and subgenomic 26S RNAs are indicated on the right. (C) Densitom-
etry analysis was performed on the intensities of cellular RNA bands
labeled with an asterisk (left panel) or two asterisks (right panel) in
panel B between 2 and 5 hpi. Data are averages from four experiments,
and error bars are standard deviations.
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were therefore clearly activated early in infection by both vi-
ruses.
DISCUSSION
The discoveries of many viral suppressors of the type I IFN
response (reviewed in reference 18) illustrate the potency of
this pathway in the control of virus infections. Pathogenic vi-
ruses have evolved in many ways to inhibit the host’s ability to
respond to infection, and these suppressive effects are found in
most stages of the pathway. Suppressors include viral proteins
that can block the initial activation of the upstream sensors of
viral infection (retinoic acid-inducible gene I and melanoma
differentiation-associated factor 5) (6, 8, 11), block the activa-
tion and nuclear entry of type I IFN transcription factors (4, 5,
24, 36, 38), inhibit general transcription (1, 7, 9, 39), act as
decoy type I IFN receptors (2), and block the downstream type
I IFN effector molecules (19, 23).
In this study we have analyzed the interactions between SFV
and the type I interferon response in mouse embryo fibroblasts.
Our tool was the virus mutant SFV4-RDR, which differs from
SFV4 by a single point mutation in the RRR (wt) nuclear local-
ization signal within nsp2. Early work with this virus in mice
showed that an intact type I IFN interferon system could atten-
uate the neurovirulence of SFV4-RDR but not the neuroviru-
lence of SFV4 (10, 33). Here we show that relative to SFV4,
infection of MEFs with SFV4-RDR resulted in increased expres-
sion of type I IFN genes and increased levels of functional inter-
feron and the proinflammatory cytokine TNF-.
Several RNA viruses block the cell’s ability to produce large
amounts of type I IFN by blocking general cellular gene ex-
pression. In these viral infections, constitutively active tran-
scription factors are inactivated and total cellular transcription
is blocked, including that of type I IFN genes and other infec-
tion-stimulated genes. In many cases, inhibition of cellular
RNA synthesis is accompanied by translational shutoff, possi-
bly aiding the immediate cessation of cellular gene expression
(1, 9). Recent work with nsp2 mutants of the related Sindbis
alphavirus suggests that this virus also causes a general inhibi-
tion of cellular RNA synthesis, resulting in inhibition of the
type I IFN system (13, 16). The SIN nsp2 mutant SIN/G, which
is incapable of inhibiting cellular protein and RNA synthesis in
infected murine cells, induces a significant increase in type I
IFN relative to that with the parental virus. The SIN2V mutant
also induces high levels of IFN relative to those with the pa-
rental virus but causes only a partial shutoff of cellular tran-
scription. In contrast, our SFV4-RDR mutant replicates with
kinetics comparable to those of SFV4 and induces similar
levels of global transcription and translation shutoff but nev-
ertheless induces significantly more type I IFN. This indicates
that the differences in cytokine responses are not due to an
inability of SFV4-RDR to globally suppress host cell macro-
molecular synthesis.
Two explanations must be considered for these differences;
first, that SFV4-RDR activates the IFN system more efficiently
than SFV4 does, and second, that SFV4 has the ability to
specifically suppress IFN induction, while the ability of SFV4-
RDR to do this has been reduced or lost. It is difficult to
separate these possibilities, but since nuclear translocation of
the key interferon-inducing transcription factors IRF-3 and
FIG. 4. (A) The kinetics of protein synthesis at early times postin-
fection in SFV4-infected (upper panel) or SFV4-RDR-infected (lower
panel) MEFs (each at a MOI of 10) was analyzed by [35S]methionine
labeling. Positions of cellular actin and viral p62, E1, and capsid pro-
teins are indicated on the right. (B) Densitometry was performed on
the intensity of the band corresponding to actin. Data are averages
from three experiments, and error bars are standard deviations.
(C) The phosphorylation state of eIF2 in these cells 5 h postinfection
or mock infection (M) was determined by immunoblotting for phos-
pho-eIF2 (upper panel) and related to total eIF2 by stripping and
reprobing the membrane (lower panel).
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NF-B occurred with equal kinetics in all virus-infected cells,
in both SFV4- and SFV4-RDR-infected cultures, we conclude
that both viruses efficiently activate early events in the induc-
tion of type I IFN gene expression. nsp2 of SFV must therefore
have the ability to suppress the induction of type I IFN at some
point in the gene induction pathway beyond the nuclear trans-
location of these transcription factors. SFV4 and SFV4-RDR
differ in a single amino acid in the nuclear localization signal of
nsp2; while it is tempting to speculate that translocation of
nsp2 to the nucleus in SFV4-infected cells is required for
suppression of the IFN system, the possibility that the RDR
mutation affects a function of nsp2 manifest in the cytoplasm
cannot be ruled out.
The observation that the levels of another virus-induced
cytokine, TNF-, were also increased in SFV4-RDR-infected
cells points to a non-IFN-specific effect on host cell gene ex-
pression. It is possible that a larger group of genes is inhibited
by nsp2 via inhibition of the activity of a particular transcrip-
tion factor, such as, for example, NF-B. Alternatively, it is
possible that the nuclear fraction of nsp2 may inhibit transcrip-
tion on a more general level in a manner similar to those
discussed for other RNA viruses. Either way, an nsp2-depen-
dent mechanism exists to inhibit the production of cellular
transcripts which are strongly promoted soon after virus infec-
tion, for example, host response cytokines. However, as we
have shown that both SFV4 and SFV4-RDR lead to inhibition
of host transcription by a common global mechanism but differ
in their levels of type I IFN and TNF- induction, the relative
contributions of specific and general transcription inhibition
mechanisms to these differences cannot be readily determined.
The SFV nsp2 protein has a number of activities which could
be involved in the inhibition of host responses (15, 26, 29, 33,
34). Notably, it contains a papain-like protease domain which
is primarily responsible for the processing of the nsp1234
polyprotein and maturation of the viral replicase complex (29,
40). Other RNA viruses encode proteases which are trans-
ported to the nucleus and result in the cleavage of cellular
transcription factors (3). It is possible that SFV4 nsp2 protease
activity is maintained upon nuclear entry and that this is re-
sponsible for the inhibition of the type I IFN response. The
observation that cellular DNA synthesis is inhibited by SFV4
but not by SFV4-RDR (33) suggests that nuclear entry of nsp2
has clear effects on the metabolism of the host cell. How nsp2
antagonizes transcription of cellular innate immune signaling
genes remains to be elucidated.
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